A Study to Assess Adjunctive NBI-1065845 in Adult Subjects With Major Depressive Disorder (MDD) (H-51059)

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adult Subjects With Major Depressive Disorder (MDD)

Is depression making you miss out?

If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you.

Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost.

Participants in the SAVITRI Study must:

• Be 18 to 65 years of age
• Have a confirmed diagnosis of MDD
• Be currently on antidepressant medication(s)
• Have had inadequate response to up to 5 oral antidepressant medications
• Not be pregnant or breastfeeding

Participants will receive study-related medical care and investigational study medication at no cost and may be eligible for compensation for time and travel.